Wuppertal, Germany

Heinz Forster


Average Co-Inventor Count = 4.0

ph-index = 9

Forward Citations = 288(Granted Patents)

Forward Citations (Not Self Cited) = 241(Oct 12, 2025)


Inventors with similar research interests:


Location History:

  • Wuppertal-Elberfeld, DE (1981)
  • Wuppertal, DE (1977 - 1995)
  • Kadenbach, DE (1997 - 2013)

Company Filing History:


Years Active: 1977-2013

Loading Chart...
59 patents (USPTO):Explore Patents

Title: **Heinz Forster: A Pioneer in Cancer Treatment Innovations**

Introduction

Heinz Forster, based in Wuppertal, Germany, is an accomplished inventor known for his significant contributions to cancer treatment through innovative chemical compounds. With an impressive portfolio of 59 patents, Forster has made notable advancements in the medical field, particularly through the development of novel triazene compounds.

Latest Patents

One of Forster's latest inventions focuses on triazene compounds specifically designed for the treatment of cancer. This invention details novel triazene compounds, including a process for their preparation and pharmaceutical compositions containing these compounds. Importantly, these new triazene compounds are characterized by their improved efficacy compared to existing compounds while exhibiting reduced toxicity. This advancement promises fewer side effects for patients undergoing cancer treatment, marking a significant step forward in chemotherapy.

Career Highlights

Throughout his career, Heinz Forster has worked for prominent companies in the pharmaceutical industry, most notably Bayer Aktiengesellschaft and Trin Therapeutics GmbH. His tenure at these organizations allowed him to cultivate innovative ideas that eventually led to his groundbreaking patents.

Collaborations

Forster has collaborated with notable figures in the research community, including Robert R. Schmidt and Ludwig Eue. These partnerships have played a crucial role in enhancing his research efforts and expanding his impact within the field of cancer treatment.

Conclusion

Heinz Forster's dedication to innovation in the pharmaceutical industry is evident through his extensive patent portfolio and collaborative endeavors. His work on triazene compounds exemplifies his commitment to developing effective treatments with reduced side effects, which could drastically improve the quality of life for cancer patients. As his research continues to evolve, Forster is poised to remain a key figure in the ongoing fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…